Eli Lilly

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Eli Lilly 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About LLY

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. 

CEO
David A. Ricks
CEODavid A. Ricks
Employees
50,000
Employees50,000
Headquarters
Indianapolis, Indiana
HeadquartersIndianapolis, Indiana
Founded
1876
Founded1876
Employees
50,000
Employees50,000

LLY Key Statistics

Market cap
1.17T
Market cap1.17T
Price-Earnings ratio
42.66
Price-Earnings ratio42.66
Dividend yield
0.51%
Dividend yield0.51%
Average volume
2.53M
Average volume2.53M
High today
$1,264.83
High today$1,264.83
Low today
$1,230.98
Low today$1,230.98
Open price
$1,262.14
Open price$1,262.14
Volume
1.66M
Volume1.66M
52 Week high
$1,292.65
52 Week high$1,292.65
52 Week low
$694.23
52 Week low$694.23

Stock Snapshot

Eli Lilly(LLY) stock is priced at $1,249.50, giving the company a market capitalization of 1.17T. It carries a P/E multiple of 42.66 and pays a dividend yield of 0.51%.

On 2026-08-24, Eli Lilly(LLY) stock traded between a low of $1,230.98 and a high of $1,264.83. Shares are currently priced at $1,249.50, which is +1.5% above the low and -1.2% below the high.

The Eli Lilly(LLY)'s current trading volume is 1.66M, compared to an average daily volume of 2.53M.

During the past year, Eli Lilly(LLY) stock moved between $694.23 at its lowest and $1,292.65 at its peak.

During the past year, Eli Lilly(LLY) stock moved between $694.23 at its lowest and $1,292.65 at its peak.

LLY News

TipRanks 1h
Eli Lilly Stock in Focus as Hedge Fund Titan Ken Griffin Quadruples Position

Eli Lilly’s (LLY) stock is garnering attention on reports that hedge fund titan Ken Griffin nearly quadrupled his stake in the pharmaceutical company during the...

Quartz 3h
FDA clears Roche and Eli Lilly's Alzheimer's blood test for primary and specialty care - qz.com

...

FDA clears Roche and Eli Lilly's Alzheimer's blood test for primary and specialty care - qz.com
TipRanks 4h
Lilly Targets COPD Growth With New Brenipatide Phase 2 Trial

Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium to make smarter, more co...

Analyst ratings

82%

of 33 ratings
Buy
81.8%
Hold
12.1%
Sell
6.1%

More LLY News

TipRanks 4h
Eli Lilly’s New Obesity Drug LY3549492 Moves Forward With Completed Phase 1 Trial

Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium to make smarter, more co...

24/7 Wall St. 5h
Eli Lilly Has a $100 Billion Revenue Story in the Making, 18% Upside Ahead

It sounds nuts, but SoFi1 is giving new Active Invest users up to $3,000 in stock for a limited time, and all it takes is a $50 deposit to get started.2 See for...

Eli Lilly Has a $100 Billion Revenue Story in the Making, 18% Upside Ahead
Simply Wall St 5h
Eli Lilly On Foundayo Launch And Higher Outlook Faces A Rich Valuation

Eli Lilly (LLY) has moved further into obesity and diabetes care with the UK launch of its once daily oral GLP-1 pill Foundayo, orforglipron, shortly after lift...

Eli Lilly On Foundayo Launch And Higher Outlook Faces A Rich Valuation
TipRanks 8h
Eli Lilly Stock Gains on FDA Approval for Alzheimer’s Blood Test Developed with Roche

Shares in Eli Lilly (LLY) edged higher to around $1,261 per share during Monday’s pre-market session. This followed the U.S. Food and Drug Administration’s (FDA...

Nasdaq 22h
Eli Lilly and Novo Nordisk Can't Treat This Form of Obesity. Billionaire Stanley Druckenmiller Is Betting Rhythm Pharmaceuticals Can

Key Points Rhythm Pharmaceuticals develops medicines for rare forms of obesity. The company has little competition in its target market. The stock looks prom...

Eli Lilly and Novo Nordisk Can't Treat This Form of Obesity. Billionaire Stanley Druckenmiller Is Betting Rhythm Pharmaceuticals Can
Nasdaq 1d
Billionaire Ken Griffin Just Loaded Up on Eli Lilly Stock. Should You?

Key Points Griffin's Citadel hedge fund nearly quadrupled its stake in Eli Lilly in Q2. Lilly's diabetes and obesity drugs continue to enjoy impressive moment...

Billionaire Ken Griffin Just Loaded Up on Eli Lilly Stock. Should You?
Simply Wall St 3d
Veeva Systems Could Be 23% Undervalued On Eli Lilly Win And Leadership Shift

Eli Lilly’s decision to adopt Veeva Systems (VEEV) Vault CRM globally, combined with an upcoming leadership change in sales and services, gives investors new co...

Veeva Systems Could Be 23% Undervalued On Eli Lilly Win And Leadership Shift

People also own

Based on the portfolios of people who own LLY. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.